The most common error related to the use of metered dose inhalers was the failure to attach the inhaler to a spacer. SAN ANTONIO — In the United States, two-thirds ...

The genius of metered-dose inhaler design lies in its ability to generate a mist of medicine that can be breathed deeply into the lungs. Placing the inhaler into the mouth diminishes this effect ...

Switching from a metered-dose inhaler to a dry powder version for maintenance therapy more than halves the carbon footprint of people with asthma, and without any worsening of their condition, finds a ...

Struggling with your asthma medicine? An asthma inhaler works most effectively if you deliver your medication slowly, so this is where a spacer device can be useful to help you achieve this goal. Many ...

Switching from a metered dose inhaler to a dry powder version for maintenance therapy more than halves the carbon footprint of people with asthma, and without any worsening of their condition, finds a ...

BreatheSuite Inc., a Canadian connected respiratory health company, today announced that it has received 510(K) clearance from the U.S. Food and Drug Administration (FDA) for its BreatheSuite ...

There was a notable gap in effectiveness between metered-dose and dry-powder formulations of single-inhaler triple therapy for chronic obstructive pulmonary disease (COPD), according to real-world ...

A research report in the Annals of Pharmacotherapy is the first published study to compare the acceptability and inhaler technique for available asthma and/or COPD inhaler devices in a community ...

Summer temperatures, humidity and allergies are triggers for people diagnosed with asthma. These triggers can range from being a nuisance to being life-threatening. Dr. Jacqueline Squire, a Mayo ...

Please provide your email address to receive an email when new articles are posted on . BreatheSuite announced that it received 510(k) clearance from the FDA for its Metered-Dose Inhaler V1 device, ...

The pros and cons to using a dry powder inhaler as treatment for chronic obstructive pulmonary disease. Neil Minkoff, MD: Dr Drummond, we’ve talked a little bit about the differences. You brought some ...